Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 13Colorectal Neoplasms 13Neoplasm Metastasis 7Small Cell Lung Carcinoma 4Neuroblastoma 4Lung Neoplasms 4Sarcoma 3Rhabdomyosarcoma 3Colonic Neoplasms 3Cholangiocarcinoma 3Biliary Tract Neoplasms 3Stomach Neoplasms 2Sarcoma, Ewing 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Refractory Solid Tumors 1Recurrence 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1

Interventions

paricalcitol 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Irinotecan × 30 days × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡